Eyebright Medical Technology (Beijing) Balance Sheet Health
Financial Health criteria checks 5/6
Eyebright Medical Technology (Beijing) has a total shareholder equity of CN¥2.5B and total debt of CN¥614.8M, which brings its debt-to-equity ratio to 24.2%. Its total assets and total liabilities are CN¥3.4B and CN¥863.1M respectively. Eyebright Medical Technology (Beijing)'s EBIT is CN¥412.0M making its interest coverage ratio 34.3. It has cash and short-term investments of CN¥469.3M.
Key information
24.2%
Debt to equity ratio
CN¥614.83m
Debt
| Interest coverage ratio | 34.3x |
| Cash | CN¥469.25m |
| Equity | CN¥2.54b |
| Total liabilities | CN¥863.14m |
| Total assets | CN¥3.41b |
Recent financial health updates
Recent updates
We Think That There Are Some Issues For Eyebright Medical Technology (Beijing) (SHSE:688050) Beyond Its Promising Earnings
Nov 06
Returns At Eyebright Medical Technology (Beijing) (SHSE:688050) Are On The Way Up
Oct 18Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable
Oct 01Eyebright Medical Technology (Beijing) Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 23Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)
Jul 15Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings
Jun 10Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?
May 13Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues
Apr 24Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think
Apr 21Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Mar 25A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)
Mar 18Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)
Mar 01Financial Position Analysis
Short Term Liabilities: 688050's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥247.5M).
Long Term Liabilities: 688050's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥615.6M).
Debt to Equity History and Analysis
Debt Level: 688050's net debt to equity ratio (5.7%) is considered satisfactory.
Reducing Debt: 688050's debt to equity ratio has increased from 0.1% to 24.2% over the past 5 years.
Debt Coverage: 688050's debt is well covered by operating cash flow (48.6%).
Interest Coverage: 688050's interest payments on its debt are well covered by EBIT (34.3x coverage).